ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 128 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $28,000 | -83.3% | 2,877 | -79.1% | 0.00% | – |
| Q4 2020 | $168,000 | +290.7% | 13,796 | +231.5% | 0.00% | – |
| Q3 2020 | $43,000 | -65.9% | 4,162 | -30.3% | 0.00% | – |
| Q2 2020 | $126,000 | +59.5% | 5,971 | -12.4% | 0.00% | – |
| Q4 2019 | $79,000 | +203.8% | 6,817 | +44.0% | 0.00% | – |
| Q3 2019 | $26,000 | -51.9% | 4,735 | +5.2% | 0.00% | – |
| Q2 2019 | $54,000 | +2600.0% | 4,502 | +486.2% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 768 | +104.3% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 376 | -2.8% | 0.00% | – |
| Q2 2018 | $2,000 | -33.3% | 387 | -64.5% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 1,089 | +34.6% | 0.00% | – |
| Q3 2016 | $3,000 | 0.0% | 809 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | – | 809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |